Lupus Drug Shows Promising Results - WSJ.com
Links shared publicly online about this topic.
- 1,632total visits
Lupus Drug Shows Promising Results - WSJ.com
View full resource at online.wsj.com
Tags: Autoimmune Disease, Lupus, Disease and Condition, Drug, GlaxoSmithKline
Most Recently Shared on November 2, 2009 at 9:58 am By:
Lupus Drug Shows Promising Results http://bit.ly/15VeW2
Antifolates show promise against lung cancer subtype - News
virtualmedicalcentre.com — “Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study.” View full resource at virtualmedicalcentre.com
Most Recently Shared on November 25, 2011 at 1:14 pm By:
VirtualMedicalCentre Health Site
Antifolates show promise against lung cancer subtype http://t.co/JYHEur01 #Healthnews
Antifolates show promise against NSCLC subtype
eurekalert.org — “Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study conducted by Quintiles comparing human lung cancer cell lines and patients.” View full resource at eurekalert.org
Most Recently Shared on November 14, 2011 at 8:05 pm By:
Antifolates show promise against NSCLC subtype: (American Association for Cancer Research) Patients with non-sma... http://t.co/uVA7df4F
Merck's prospect for Alzheimer's disease shows early promise | NJ.com
nj.com — “In an annual business briefing with industry analysts and the media, top researchers from the pharmaceutical company discussed the promising results of the first early studies of the drug candidate, which is known now only as MK-8931.” View full resource at nj.com
Most Recently Shared on November 10, 2011 at 10:49 pm By:
Merck's prospect for Alzheimer's disease shows early promise: In an annual business briefing with industry analy... http://t.co/FpWq2BIi
ADHD Drug Lisdexamfetamine Dimesylate (LDX) Shows Promise For Children And Adolescents
medicalnewstoday.com — “Shire plc presented positive top-level results of their first European phase III study of lisdexamfetamine dimesylate (LDX), designed for children and adolescents aged 6 to 17 years with Attentio” View full resource at medicalnewstoday.com
Most Recently Shared on October 23, 2011 at 7:23 pm By:
OrganizedWisdom ADHD OW Health and Active Health Library
ADHD Drug Lisdexamfetamine Dimesylate (LDX) Shows Promise For Children And Adolescents: Shire plc presente... http://t.co/BL5QuqLW #ADHD
ADHD Drug Lisdexamfetamine Dimesylate (LDX) Shows Promise For Children And Adolescents
medicalnewstoday.com — “Shire plc presented positive top-level results of their first European phase III study of lisdexamfetamine dimesylate (LDX), designed for children and adolescents aged 6 to 17 years with Attentio” View full resource at medicalnewstoday.com
Most Recently Shared on October 23, 2011 at 5:05 pm By:
ADHD Drug Lisdexamfetamine Dimesylate (LDX) Shows Promise For Children And Adolescents http://t.co/n1M17IAu #healthnews
Experimental MS Drug Shows Promise - iVillage
ivillage.com — “WEDNESDAY, Oct. 5 (HealthDay News) -- A new oral drug for relapsing forms of multiple sclerosis appears to reduce relapse rates and disability progression, according to the results of a so-called phase 3 trial. The experimental drug, terifluno” View full resource at ivillage.com
Most Recently Shared on October 8, 2011 at 7:25 pm By:
Experimental MS Drug Shows Promise http://ow.ly/6PAxe
Roche HDL Cholesterol Drug Shows Early Promise - QualityPoint Technologies
qualitypointtech.net — “An experimental drug from Roche designed to raise HDL cholesterol has produced encouraging results in a small mid-stage clinical trial. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on August 24, 2011 at 1:45 am By:
Roche HDL Cholesterol Drug Shows Early Promise: An experimental drug from Roche designed to raise HDL cholesterol ... http://t.co/eqOHs3q
AstraZeneca Ovarian Cancer Drug Shows Promise for Aggressive Disease
emaxhealth.com — “The results of the second Phase II study involving AstraZeneca’s olaparib have been released, and the news is promising that the drug is a new treat...” View full resource at emaxhealth.com
Most Recently Shared on August 23, 2011 at 1:54 pm By:
Denise Reynolds RD Nutritionist and Dietitian
AstraZeneca Ovarian Cancer Drug Shows Promise for Aggressive Disease http://t.co/Yxuc1r7
HDL Cholesterol Drug Shows Promising Early Results | ThirdAge
thirdage.com — “Patients taking HDL cholesterol drug Dalcetrapib had less build-up of potentially artery-clogging plaque in their blood vessel walls than patients taking the placebo” View full resource at thirdage.com
Most Recently Shared on August 23, 2011 at 12:22 pm By:
HDL Cholesterol Drug Shows Promising Early Results http://t.co/CBYZ8eL
Researchers demonstrate green tea is effective in treating genetic disorder and types of tumors
labspaces.net — “A compound found in green tea shows great promise for the development of drugs to treat two types of tumors and a deadly congenital disease. The discovery is the result of research led by Principal Investigator, Dr. Thomas Smith at The Donald Danforth Plant Science Center and his colleagues at The Children's Hospital of Philadelphia.” View full resource at labspaces.net
Most Recently Shared on August 17, 2011 at 4:45 pm By:
Researchers demonstrate green tea is effective in treating genetic disorder and types of tumors - http://t.co/mXM0xrp
Green tea shows promise against two types of tumors, HHS
news-medical.net — “A compound found in green tea shows great promise for the development of drugs to treat two types of tumors and a deadly congenital disease. The discovery is the result of research led by Principal Investigator, Dr. Thomas Smith at The Donald Danforth Plant Science Center and his colleagues at The Children's Hospital of Philadelphia.” View full resource at news-medical.net
Most Recently Shared on August 16, 2011 at 9:54 am By:
Green tea shows promise against two types of tumors, HHS: A compound found in green tea shows great promise for ... http://t.co/i3sUBQ7
New Non-Invasive Technology Shows Promise in Shrinking Liver Tumors
newswise.com — “The therapy uses very low electromagnetic frequencies without medications or chemotherapy and showed significant results in a phase II study.” View full resource at newswise.com
Most Recently Shared on August 9, 2011 at 7:40 pm By:
New Non-Invasive Technology Shows Promise in Shrinking Liver Tumors: The therapy uses very low electroma... http://bit.ly/oS20uu #cancer
Genentechs New Drug Shows Promise in Fighting
biospace.com — “Researchers say a new drug targeting a specific gene in people with advanced breast cancer has shown hopeful results since being put under the” View full resource at biospace.com
Most Recently Shared on August 5, 2011 at 4:24 pm By:
Raymond DuBois Gastroenterologist, Health Executive, Physician, Doctor, and Internist
Genentech's New Drug Shows Promise in Fighting Breast Cancer: http://t.co/5gCk1xa
Late-stage ovarian cancer therapy shows promise in phase II trial
medicalxpress.com — “An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conducting a larger clinical trial to test the therapy and to see how it compares with existing treatments for ...” View full resource at medicalxpress.com
Most Recently Shared on August 3, 2011 at 6:10 pm By:
PhysOrg Health News Health News
Late-stage ovarian cancer therapy shows promise in phase II trial http://tw.medicalxpress.com/231598840
Late-Stage Ovarian Cancer Therapy Shows Promise In Phase II Trial
medicalnewstoday.com — “An experimental two-drug combination for treating late-stage ovarian cancer continues to produce strong results, leading its Indiana University researchers to actively pursue the next step, conduc” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2011 at 8:05 am By:
MNT Clinical Trials Health News
Late-Stage Ovarian Cancer Therapy Shows Promise In Phase II Trial http://mnt.to/3YHH #clinicaltrials
Advertisement
